Beijing Winsunny Pharmaceutical CO.LTD (601089) — Cash Flow Quality Index
Beijing Winsunny Pharmaceutical CO.LTD (601089) has a Cash Flow Quality Index of 1.41x as of December 2024. Operating cash flow of CN¥690.75 Million exceeds net income of CN¥488.67 Million, indicating high earnings quality where cash backs reported profits. Also explore Beijing Winsunny Pharmaceutical CO.LTD balance sheet assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Beijing Winsunny Pharmaceutical CO.LTD Cash Flow Quality Index (2020–2024)
Historical Cash Flow Quality Index for Beijing Winsunny Pharmaceutical CO.LTD across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 601089 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Beijing Winsunny Pharmaceutical CO.LTD (2020–2024)
Year-by-year earnings quality comparison for Beijing Winsunny Pharmaceutical CO.LTD. For live market cap and the full company financial profile, see Beijing Winsunny Pharmaceutical CO.LTD (601089) market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.41x | CN¥690.75 Million | CN¥488.67 Million | ▲ +24.3% |
| 2023 | 1.14x | CN¥555.90 Million | CN¥488.77 Million | ▼ -24.4% |
| 2022 | 1.50x | CN¥659.76 Million | CN¥438.46 Million | ▼ -9.3% |
| 2021 | 1.66x | CN¥528.02 Million | CN¥318.12 Million | ▲ +12.8% |
| 2020 | 1.47x | CN¥386.65 Million | CN¥262.71 Million | — |